INVO Bioscience, Inc. (INVO) - Net earnings per share (EPS TTM)
The availability of the INVOcell system expands the ART market reach, impacting the trailing 12-month earnings per share dynamics for INVO Bioscience, Inc. (INVO). Management's strategy to develop a network of proprietary clinics and a patented reproduction ecosystem strengthens financial stability. The current price trajectory on the chart is trending toward the level where -30.56 records this metric, helping to assess the real growth of the business.
INVO (INVO Bioscience Inc.): analytical breakdowns and indicator data
- share price and expert price forecast:
- market capitalization indicators:
- business book valuation details:
- debt and liquidity details:
Debt to Equity INVO Bioscience, Inc.|INVO - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital INVO Bio|INVO - Company Cumulative Debt|Debts to Book Capitalization INVO Bioscience, Inc.|INVO - Company Long-Term Indebtedness|Company Short-Term Debts INVO Bioscience|Quick Ratio invobioscience.com
- net income and valuation multiples indicators:
INVO - Net Income|Projected Future Earnings INVO Bioscience, Inc.|INVO - P/E Multiple|Future Price to Earnings INVO Bio|INVO - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio INVO Bioscience, Inc.|INVO - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) INVO Bioscience|INVO - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months invobioscience.com|INVO - Net earnings per share change in current year|Expected earnings per share growth for next year INVO Bioscience, Inc.
Basic company analysis:invobioscience.com (INVO)
INVO Bioscience, Inc. (INVO) is scaling its clinic network by introducing an affordable alternative to IVF via INVOcell technology. The efficiency of this expansion is reflected in the distribution of total net income across all outstanding shares. This metric measures the actual profit share per share over the last 12 months. Growth in this indicator confirms an increase in the business's intrinsic value. By analyzing the company's rolling annual earnings per share, an investor determines the fundamental stability of the asset.
Direct competitors
BSX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months EW|RMD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insulet Corp (PODD)|ZBH (Zimmer Biomet Holdings) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months COO (CooperSurgical)|Net earnings per share for the last 12 months ALGN (Align Technology, Inc.)|GMED (globusmedical.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months TransMedics Group Inc TMDX|ATEC - Net earnings per share for the last 12 months|Artivion Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Enovis Inc.|IART: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months ESTA|BBNX (Beta Bionics) - Net earnings per share (EPS TTM)|IRADIMED Corp (IRMD) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) EMBC|Net earnings per share for the last 12 months Tandem Corp TNDM|Net earnings per share (EPS TTM) AXGN (AxoGen, Inc.)|Net earnings per share (EPS TTM) si-bone.com SIBN|OFIX - Earnings per share for the last twelve months|BVS: Earnings per share for the last twelve months|KIDS (orthopediatrics.com) - Net earnings per share for the last 12 months|Treace Corp - Earnings per share for the trailing year|SRTA (Strata Critical Medical Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months carlsmed.com CARL|Earnings per share for the last twelve months RxSight (RXST)|clearpointneuro.com (CLPT) - Net earnings per share for the trailing year|Stereotaxis Corp - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Neuronetics, Inc STIM|Sight Sciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Orchestra BioMed Inc. OBIO|anikatherapeutics.com (ANIK) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months NSPR (InspireMD Inc)|Earnings per share for the last twelve months Jin Medical International Ltd.|Net earnings per share for the last 12 months Vivani (VANI)|Net earnings per share (EPS TTM) XTNT|NMTC - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Modular Medical, Inc. MODD|MYO: Earnings per share for the last 12 months|COCH: Net earnings per share for the last 12 months|Vivos Therapeutics Inc - Earnings per share for the last four quarters|NVNO: Net earnings per share (EPS TTM)|SINT - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Tenon Medical|Earnings per share for the last 12 months LFWD (ReWalk Robotics)|Net earnings per share for the last 12 months AMIX (Autonomix Medical, Inc.)|Earnings per share for the last twelve months IVF (INVO Fertility Corp)|Earnings per share for the last twelve months Bone Biologics BBLG|axonics.com (AXNX) - Net earnings per one share for the last twelve months|BIOL: Net earnings per share for the last 12 months|Earnings per share for the trailing year DYNT (Dynatronics Corporation)|FNA: Net earnings per share (EPS TTM)
